Neuroinflammation and microglial activation are significant processes in Alzheimer's disease pathology. Recent genome-wide association studies have highlighted multiple immune-related genes in association with Alzheimer's disease, and experimental data have demonstrated microglial proliferation as a significant component of the neuropathology. In this study, we tested the efficacy of the selective CSF1R inhibitor JNJ-40346527 (JNJ-527) in the P301S mouse tauopathy model. We first demonstrated the anti-proliferative effects of JNJ-527 on microglia in the ME7 prion model, and its impact on the inflammatory profile, and provided potential CNS biomarkers for clinical investigation with the compound, including pharmacokinetic/pharmacodynamics and efficacy assessment by TSPO autoradiography and CSF proteomics. Then, we showed for the first time that blockade of microglial proliferation and modification of microglial phenotype leads to an attenuation of tau-induced neurodegeneration and results in functional improvement in P301S mice. Overall, this work strongly supports the potential for inhibition of CSF1R as a target for the treatment of Alzheimer's disease and other tau-mediated neurodegenerative diseases.

CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice / R. Mancuso, G. Fryatt, M. Cleal, J. Obst, E. Pipi, J. Monzon-Sandoval, E. Ribe, L. Winchester, C. Webber, A. Nevado, T. Jacobs, N. Austin, C. Theunis, K. Grauwen, E.D. Ruiz, A. Mudher, M. Vicente-Rodriguez, C.A. Parker, C. Simmons, D. Cash, J. Richardson, D.N.C. Jones, S. Lovestone, D. Gomez-Nicola, V. Hugh Perry, E.T. Bullmore, J. Bhatti, S.J. Chamberlain, M.M. Correia, A.L. Crofts, A. Dickinson, A.C. Foster, M.G. Kitzbichler, C. Knight, M.-. Lynall, C. Maurice, C. O'Donnell, L.J. Pointon, P. St George Hyslop, L. Turner, P. Vertes, B. Widmer, G.B. Williams, B. Paul Morgan, C.A. Leckey, A.R. Morgan, C. O'Hagan, S. Touchard, J. Cavanagh, C. Deith, S. Farmer, J. Mcclean, A. Mccoll, A. Mcpherson, P. Scouller, M. Sutherland, H.W.G.M. Boddeke, J.C. Richardson, S. Khan, P. Murphy, C.A. Parker, J. Patel, D. Jones, P. De Boer, J. Kemp, W.C. Drevets, J.S. Nye, G. Wittenberg, J. Isaac, A. Bhattacharya, N. Carruthers, H. Kolb, C.M. Pariante, F. Turkheimer, G.J. Barker, H. Byrom, D. Cash, A. Cattaneo, A. Gee, C. Hastings, N. Mariani, A. Mclaughlin, V. Mondelli, M. Nettis, N. Nikkheslat, K. Randall, H. Sheridan, C. Simmons, N. Singh, V. Van Loo, M. Vicente-Rodriguez, T.C. Wood, C. Worrell, Z. Zajkowska, N. Plath, J. Egebjerg, H. Eriksson, F. Gastambide, K.H. Adams, R. Jeggo, C. Thomsen, J.T. Pederson, B. Campbell, T. Moller, B. Nelson, S. Zorn, J. O'Connor, M.J. Attenburrow, A. Baird, J. Benjamin, S. Clare, P. Cowen, I.-. Huang, S. Hurley, H. Jones, S. Lovestone, F. Mada, A. Nevado-Holgado, A. Oladejo, E. Ribe, K. Smith, A. Vyas, Z. Hughes, R. Balice-Gordon, J. Duerr, J.R. Piro, J. Sporn, V. Hugh Perry, M. Cleal, G. Fryatt, D. Gomez-Nicola, R. Mancuso, R. Reynolds, N.A. Harrison, M. Cercignani, C.L. Clarke, E. Hoskins, C. Kohn, R. Murray, L. Wilcock, D. Wlazly, H. Mount. - In: BRAIN. - ISSN 0006-8950. - 142:10(2019 Oct), pp. 3243-3264. [10.1093/brain/awz241]

CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice

C. Maurice;S. Khan;D. Jones;A. Cattaneo;N. Singh;
2019

Abstract

Neuroinflammation and microglial activation are significant processes in Alzheimer's disease pathology. Recent genome-wide association studies have highlighted multiple immune-related genes in association with Alzheimer's disease, and experimental data have demonstrated microglial proliferation as a significant component of the neuropathology. In this study, we tested the efficacy of the selective CSF1R inhibitor JNJ-40346527 (JNJ-527) in the P301S mouse tauopathy model. We first demonstrated the anti-proliferative effects of JNJ-527 on microglia in the ME7 prion model, and its impact on the inflammatory profile, and provided potential CNS biomarkers for clinical investigation with the compound, including pharmacokinetic/pharmacodynamics and efficacy assessment by TSPO autoradiography and CSF proteomics. Then, we showed for the first time that blockade of microglial proliferation and modification of microglial phenotype leads to an attenuation of tau-induced neurodegeneration and results in functional improvement in P301S mice. Overall, this work strongly supports the potential for inhibition of CSF1R as a target for the treatment of Alzheimer's disease and other tau-mediated neurodegenerative diseases.
Alzheimer's disease; CSF1R; Microglia; Neuroinflammation; Tau
Settore BIO/14 - Farmacologia
Article (author)
File in questo prodotto:
File Dimensione Formato  
awz241.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 2.3 MB
Formato Adobe PDF
2.3 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/706258
Citazioni
  • ???jsp.display-item.citation.pmc??? 57
  • Scopus 88
  • ???jsp.display-item.citation.isi??? 81
social impact